Free Review Articles on Helicobacter pylori                                 Metatextbook

Freie Reviews über Helicobacter pylori                                 Look here for Journal Homepages

  • Helicobacter pylori
  • Probiotica
  • Stomach (Neoplasia)
  • Neoplasia (Carcinogenesis)
  • ITP (Immune thrombocytopenia)
  • Ghrelin
  • Anemia (Iron deficiency anemia)
  • Bacteria (Secretion type IV)
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12000Regular review: treatment of Helicobacter pylori infection.



    		+-nlBMJ 320(7226):31-4 (2000)
    21997Helicobacter pylori-associated gastroduodenal disease in childhood.



    		+-nlSouth Med J 90(6):570-6; quiz 577 (1997)
    31998Current regimens for treatment of Helicobacter pylori infection.



    		+-nlBr Med Bull 54(1):195-205 (1998)
    41998Microbiological and serological diagnostic tests for Helicobacter pylori: an overview.



    		+-nlBr Med Bull 54(1):175-86 (1998)
    51998Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy.



    		+-nlBr Med Bull 54(1):121-38 (1998)
    61998H. pylori virulence factors.



    		+-nlBr Med Bull 54(1):105-20 (1998)
    71998Clinical significance of Helicobacter infection in children.



    		+-nlBr Med Bull 54(1):95-103 (1998)
    81998Non-gastrointestinal consequences of Helicobacter pylori infection.



    		+-nlBr Med Bull 54(1):87-93 (1998)
    91998Helicobacter pylori infection and gastric lymphoma.



    		+-nlBr Med Bull 54(1):79-85 (1998)
    101998Helicobacter pylori infection and cancer.



    		+-nlBr Med Bull 54(1):71-8 (1998)
    111998Helicobacter pylori infection and non-ulcer dyspepsia.



    		+-nlBr Med Bull 54(1):63-9 (1998)
    121998Clinical science of Helicobacter pylori infection: ulcers and NSAIDs.



    		+-nlBr Med Bull 54(1):55-62 (1998)
    131998Epidemiology of Helicobacter pylori: acquisition, transmission, population prevalence and disease-to-infection ratio.



    		+-nlBr Med Bull 54(1):39-53 (1998)
    141998Helicobacter pylori--molecular genetics and diagnostic typing.



    		+-nlBr Med Bull 54(1):31-8 (1998)
    151998Helicobacter--species classification and identification.



    		+-nlBr Med Bull 54(1):17-30 (1998)
    162000Helicobacter pylori-related disease: guidelines for testing and treatment.



    		+-nlArch Intern Med 160(9):1285-91 (2000)
    171999Non-gastrointestinal tract associations of Helicobacter pylori infection.



    		+-nlArch Intern Med 159(9):925-40 (1999)
    181998Treatment of Helicobacter pylori infection.



    		+-nlArch Intern Med 158(8):842-51 (1998)
    192005A clinician's guide to managing Helicobacter pylori infection.



    		+-nlCleve Clin J Med 72(2):109-10, 112-3, 117-8 passim (2005)
    202008Helicobacter pylori--the latest in diagnosis and treatment.



    		+-nlAust Fam Physician 37(8):608-12 (2008)
    212009Helicobacter pylori and gastroduodenal ulcer disease.



    		+-nlDtsch Arztebl Int 106(49):801-8 (2009)
    221998Eradication of Helicobacter pylori infection in the management of patients with dyspepsia and non-ulcer dyspepsia.



    		+-nlYale J Biol Med 71(2):125-33 (1998)
    231998Treatment of H. pylori infection: the reality.



    		+-nlYale J Biol Med 71(2):119-24 (1998)
    241998Helicobacter pylori: therapeutic targets.



    		+-nlYale J Biol Med 71(2):113-7 (1998)
    251998Accuracy and economics of Helicobacter pylori diagnosis.



    		+-nlYale J Biol Med 71(2):75-9 (1998)
    261998Structure, function and localization of Helicobacter pylori urease.



    		+-nlYale J Biol Med 71(2):63-73 (1998)
    271998Helicobacter pylori and apoptosis.



    		+-nlYale J Biol Med 71(2):53-61 (1998)
    281998Pathobiology of Helicobacter pylori infection.



    		+-nlYale J Biol Med 71(2):43-51 (1998)
    291996Helicobacter pylori and its interaction with chief and parietal cells.



    		+-nlYale J Biol Med 69(1):91-8 (1996)
    301996Gastric MALT lymphoma and Helicobacter pylori.



    		+-nlYale J Biol Med 69(1):61-8 (1996)
    311996Helicobacter pylori: bacterial factors and interaction with the epithelial cells.



    		+-nlYale J Biol Med 69(1):35-7 (1996)
    321992Pathophysiology and clinical relevance of Helicobacter pylori.



    		+-nlYale J Biol Med 65(6):625-38 (1992)
    332003Diagnostic methods for Helicobacter pylori detection and eradication.



    		+-nlBr J Clin Pharmacol 56(3):273-83 (2003)
    341997Eradication of Helicobacter pylori: an objective assessment of current therapies.



    		+-nlBr J Clin Pharmacol 43(3):223-43 (1997)
    352009Helicobacter pylori infection in gastric cancerogenesis.



    		+-nlJ Physiol Pharmacol 60(3):3-21 (2009)
    362006Guidelines in the medical treatment of Helicobacter pylori infection.



    		+-nlJ Physiol Pharmacol 57 Suppl 3(-):143-54 (2006)
    372001Helicobacter pylori infection: epidemiology, pathophysiology, and therapy.



    		+-nlArch Pharm Res 24(6):485-98 (2001)
    381999Helicobacter pylori physiology predicted from genomic comparison of two strains.



    		+-nlMicrobiol Mol Biol Rev 63(3):675-707 (1999)
    391999Metabolism and genetics of Helicobacter pylori: the genome era.



    		+-nlMicrobiol Mol Biol Rev 63(3):642-74 (1999)
    402007Helicobacter pylori detection and antimicrobial susceptibility testing.



    		+-nlClin Microbiol Rev 20(2):280-322 (2007)
    412006Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.



    		+-nlClin Microbiol Rev 19(4):597-613 (2006)
    422006Pathogenesis of Helicobacter pylori infection.



    		+-nlClin Microbiol Rev 19(3):449-90 (2006)
    432001Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.



    		+-nlClin Microbiol Rev 14(1):59-97 (2001)
    441997Helicobacter pylori.



    		+-nlClin Microbiol Rev 10(4):720-41 (1997)
    452009Helicobacter pylori and gastric adenocarcinoma.



    		+-nlClin Microbiol Infect 15(11):971-6 (2009)
    462009Helicobacter pylori and gastric cancer: possible role of microRNAs in this intimate relationship.



    		+-nlClin Microbiol Infect 15(9):806-12 (2009)
    472005Pathogenicity of Helicobacter pylori infection.



    		+-nlClin Microbiol Infect 11(8):602-10 (2005)
    482003Non-invasive techniques for the diagnosis of Helicobacter pylori infection.



    		+-nlClin Microbiol Infect 9(6):489-96 (2003)
    491998Helicobacter pylori--a conundrum of genetic diversity.



    		+-nlMicrobiology 144 ( Pt 11)(-):2925-39 (1998)
    502009Helicobacter pylori's unconventional role in health and disease.



    		+-nlPLoS Pathog 5(10):e1000544 (2009)
    512006The diverse antioxidant systems of Helicobacter pylori.



    		+-nlMol Microbiol 61(4):847-60 (2006)
    522000Lewis antigens in Helicobacter pylori: biosynthesis and phase variation.



    		+-nlMol Microbiol 36(6):1187-96 (2000)
    532007Phagocytosis and persistence of Helicobacter pylori.



    		+-nlCell Microbiol 9(4):817-28 (2007)
    542000Helicobacter pylori: epidemiology and routes of transmission.



    		+-nlEpidemiol Rev 22(2):283-97 (2000)
    552007Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.



    		+-nlAliment Pharmacol Ther 26(3):343-57 (2007)
    562007Meta-analysis: Helicobacter pylori eradication treatment efficacy in children.



    		+-nlAliment Pharmacol Ther 25(5):523-36 (2007)
    572007Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.



    		+-nlAliment Pharmacol Ther 25(2):155-68 (2007)
    582007Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer.



    		+-nlAliment Pharmacol Ther 25(2):133-41 (2007)
    592006Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection.



    		+-nlAliment Pharmacol Ther 24(2):273-80 (2006)
    602006Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?



    		+-nlAliment Pharmacol Ther 23(8):1077-86 (2006)
    612006Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.



    		+-nlAliment Pharmacol Ther 23(1):35-44 (2006)
    622005A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.



    		+-nlAliment Pharmacol Ther 22(1):45-9 (2005)
    632005Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.



    		+-nlAliment Pharmacol Ther 21(12):1411-8 (2005)
    642005Controlled trial of interventions to increase testing and treatment for Helicobacter pylori and reduce medication use in patients with chronic acid-related symptoms.



    		+-nlAliment Pharmacol Ther 21(8):1029-39 (2005)
    652005Meta-analysis: the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication.



    		+-nlAliment Pharmacol Ther 21(4):341-5 (2005)
    662005Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.



    		+-nlAliment Pharmacol Ther 21(1):91-6 (2005)
    672004Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies.



    		+-nlAliment Pharmacol Ther 20(10):1071-82 (2004)
    682004Review article: is there a link between micronutrient malnutrition and Helicobacter pylori infection?



    		+-nlAliment Pharmacol Ther 20(10):1029-34 (2004)
    692004Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review.



    		+-nlAliment Pharmacol Ther 20(10):1001-17 (2004)
    702004Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis.



    		+-nlAliment Pharmacol Ther 20(7):733-44 (2004)
    712004Review article: Deoxyribonucleic acid-based diagnostic techniques to detect Helicobacter pylori.



    		+-nlAliment Pharmacol Ther 19(11):1137-46 (2004)
    722003Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication.



    		+-nlAliment Pharmacol Ther 18(8):757-66 (2003)
    732003Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication.



    		+-nlAliment Pharmacol Ther 18(6):647-54 (2003)
    742003Triple vs quadruple therapy for treating Helicobacter pylori infection: an updated meta-analysis.



    		+-nlAliment Pharmacol Ther 18(5):543-4 (2003)
    752003Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease.



    		+-nlAliment Pharmacol Ther 18(3):279-89 (2003)
    762003Review article: the treatment of refractory Helicobacter pylori infection.



    		+-nlAliment Pharmacol Ther 17(11):1333-43 (2003)
    772003Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis.



    		+-nlAliment Pharmacol Ther 17(9):1137-43 (2003)
    782003Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients.



    		+-nlAliment Pharmacol Ther 17(1):99-109 (2003)
    792002Alteration of histological gastritis after cure of Helicobacter pylori infection.



    		+-nlAliment Pharmacol Ther 16(11):1923-32 (2002)
    802002Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy.



    		+-nlAliment Pharmacol Ther 16(7):1269-75 (2002)
    812002Review article: Helicobacter pylori infection and gastric outlet obstruction - prevalence of the infection and role of antimicrobial treatment.



    		+-nlAliment Pharmacol Ther 16(7):1203-8 (2002)
    822002Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.



    		+-nlAliment Pharmacol Ther 16(6):1047-57 (2002)
    832002Review article: Helicobacter species and hepatobiliary diseases.



    		+-nlAliment Pharmacol Ther 16(6):1037-45 (2002)
    842002Review article: an approach to Helicobacter pylori infection in the elderly.



    		+-nlAliment Pharmacol Ther 16(4):683-91 (2002)
    852002Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies.



    		+-nlAliment Pharmacol Ther 16(3):569-75 (2002)
    862002Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.



    		+-nlAliment Pharmacol Ther 16(2):167-80 (2002)
    872001A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer.



    		+-nlAliment Pharmacol Ther 15(12):1949-58 (2001)
    882001Review article: alternative antibacterial agents for Helicobacter pylori eradication.



    		+-nlAliment Pharmacol Ther 15(10):1543-7 (2001)
    892001pathogenesis of Helicobacter pylori-induced gastric inflammation.



    		+-nlAliment Pharmacol Ther 15(9):1271-90 (2001)
    902001Comparative efficacy of new investigational agents against Helicobacter pylori.



    		+-nlAliment Pharmacol Ther 15(4):487-92 (2001)
    912000Review article: the control of gastric acid and Helicobacter pylori eradication.



    		+-nlAliment Pharmacol Ther 14(11):1383-401 (2000)
    922000A systematic review of Helicobacter pylori eradication treatment schedules in children.



    		+-nlAliment Pharmacol Ther 14 Suppl 3(-):59-66 (2000)
    932000Treatment of Helicobacter pylori: an overview.



    		+-nlAliment Pharmacol Ther 14 Suppl 3(-):1-6 (2000)
    941999The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.



    		+-nlAliment Pharmacol Ther 13(6):719-29 (1999)
    951999Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management.



    		+-nlAliment Pharmacol Ther 13(2):117-27 (1999)
    961998Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori.



    		+-nlAliment Pharmacol Ther 12(9):823-37 (1998)
    972009Meta-analysis: efficacy of bovine lactoferrin in Helicobacter pylori eradication.



    		+-nlAliment Pharmacol Ther 29(7):720-30 (2009)
    982008Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication.



    		+-nlAliment Pharmacol Ther 28(7):868-77 (2008)
    992004Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis.



    		+-nlAliment Pharmacol Ther 20 Suppl 1(-):165-70 (2004)
    1002002Review article: Helicobacter pylori infection from pathogenesis to treatment--a critical reappraisal.



    		+-nlAliment Pharmacol Ther 16 Suppl 4(-):105-13 (2002)
    1012002Review article: natural history and epidemiology of Helicobacter pylori infection.



    		+-nlAliment Pharmacol Ther 16 Suppl 1(-):3-15 (2002)
    1021997Review article: urea breath tests for detecting Helicobacter pylori.



    		+-nlAliment Pharmacol Ther 11(4):641-9 (1997)
    1031997Gastric MALT-lymphoma and Helicobacter pylori infection.



    		+-nlAliment Pharmacol Ther 11 Suppl 1(-):89-94 (1997)
    1041997Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer.



    		+-nlAliment Pharmacol Ther 11 Suppl 1(-):71-88 (1997)
    1052006Genetic factors involved in the development of Helicobacter pylori-related gastric cancer.



    		+-nlCancer Sci 97(11):1129-38 (2006)
    1062005Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis.



    		+-nlCancer Sci 96(12):835-43 (2005)
    1072005Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature.



    		+-nlAm J Hematol 78(2):142-50 (2005)
    1081999Molecular and cellular activities of Helicobacter pylori pathogenic factors.



    		+-nlFEBS Lett 452(1-2):16-21 (1999)
    1092006Use and abuse of hydrogen breath tests.



    		+-nlGut 55(3):297-303 (2006)
    1102004H pylori antibiotic resistance: prevalence, importance, and advances in testing.



    		+-nlGut 53(9):1374-84 (2004)
    1112002The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases.



    		+-nlGut 50(2):273-83 (2002)
    1122001Non-pylori Helicobacter species in humans.



    		+-nlGut 49(5):601-6 (2001)
    1131999Extradigestive manifestations of Helicobacter pylori gastric infection.



    		+-nlGut 45 Suppl 1(-):I9-I12 (1999)
    1141999Are all helicobacters equal? Mechanisms of gastroduodenal pathology and their clinical implications.



    		+-nlGut 45 Suppl 1(-):I1-4 (1999)
    1151998Helicobacters are indigenous to the human stomach: duodenal ulceration is due to changes in gastric microecology in the modern era.



    		+-nlGut 43(5):721-7 (1998)
    1162009Azithromycin-containing versus standard triple therapy for Helicobacter pylori eradication: a meta-analysis.



    		+-nlWorld J Gastroenterol 15(48):6102-10 (2009)
    1172009Comparative genomics of Helicobacter pylori.



    		+-nlWorld J Gastroenterol 15(32):3984-91 (2009)
    1182008"Rescue" regimens after Helicobacter pylori treatment failure.



    		+-nlWorld J Gastroenterol 14(35):5385-402 (2008)
    1192006Precise role of H pylori in duodenal ulceration.



    		+-nlWorld J Gastroenterol 12(40):6413-9 (2006)
    1202006Third-line rescue therapy for Helicobacter pylori infection.



    		+-nlWorld J Gastroenterol 12(15):2313-9 (2006)
    1212006Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis.



    		+-nlWorld J Gastroenterol 12(1):10-6 (2006)
    1222003Helicobacter pylori. Pathology and diagnostic strategies.



    		+-nlAm J Clin Pathol 119(3):403-12 (2003)
    1231997Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.



    		+-nlAm J Manag Care 3(10):1528-34 (1997)
    1242008Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment.



    		+-nlAnn Intern Med 148(12):923-31 (2008) Jafri NS
    1252008Sequential therapy for Helicobacter pylori: a worthwhile effort for your patients.



    		+-nlAnn Intern Med 148(12):962-3 (2008)
    1262007Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication.



    		+-nlAnn Intern Med 147(8):553-62 (2007)
    1272006Improving Helicobacter pylori eradication regimens.



    		+-nlAnn Intern Med 144(2):140-1 (2006) Francois F
    1282001Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials.



    		+-nlAnn Intern Med 134(5):361-9 (2001)
    1291997Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.



    		+-nlAnn Intern Med 126(4):280-91 (1997)
    1302009Moxifloxacin-based triple therapy versus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection: a meta-analysis of randomized controlled trials.



    		+-nlIntern Med 48(24):2069-76 (2009)
    1312000Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: evaluation of antibiotic treatment.



    		+-nlIntern Med 39(4):273-4 (2000)
    1322004Helicobacter pylori persistence: biology and disease.



    		+-nlJ Clin Invest 113(3):321-33 (2004)
    1331990Helicobacter pylori (formerly Campylobacter pyloridis/pylori) 1986-1989: a review.



    		+-nlJ Clin Pathol 43(5):353-6 (1990)
    1342003Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease.



    		+-nlKeio J Med 52(3):163-73 (2003)
    1352000Helicobacter pylori.



    		+-nlPostgrad Med J 76(893):141-4 (2000)
    1361992Eradication of Helicobacter pylori: therapies and clinical implications.



    		+-nlPostgrad Med J 68(801):549-57 (1992)
    1371998Procedure guideline for carbon-14-urea breath test. Society of Nuclear Medicine.



    		+-nlJ Nucl Med 39(11):2012-4 (1998)
    1381997Helicobacter pylori: new developments and treatments.



    		+-nlCMAJ 156(11):1565-74 (1997)
    1391994Indications for treatment of Helicobacter pylori infection: a systematic overview.



    		+-nlCMAJ 150(2):189-98 (1994)
    1401994Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.



    		+-nlCMAJ 150(2):177-85 (1994)
    1412003Systematic review: Rabeprazole-based therapies in Helicobacter pylori eradication.



    		+-nlAliment Pharmacol Ther 17(6):751-64 (2003)
    1422005Events at the host-microbial interface of the gastrointestinal tract IV. The pathogenesis of Helicobacter pylori persistence.



    		+-nlAm J Physiol Gastrointest Liver Physiol 289(1):G8-12 (2005)
    1432004Eradicating H pylori.



    		+-nlBMJ 328(7453):1388-9 (2004) Delaney B
    1442010Association between helicobacter pylori and gastrointestinal symptoms in children.



    		+-nlPediatrics 125(3):e651-69 (2010)
    1452010First-line eradication of Helicobacter pylori: are the standard triple therapies obsolete? A different perspective.



    		+-nlWorld J Gastroenterol 16(31):3865-70 (2010)
    1462011Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation.



    		+-nlWorld J Gastroenterol 17(21):2585-91 (2011)
    1472011Molecular cross-talk between Helicobacter pylori and human gastric mucosa.



    		+-nlWorld J Gastroenterol 17(11):1383-99 (2011)
    1482011Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferase.



    		+-nlWorld J Gastroenterol 17(10):1249-60 (2011)
    1492011A new look at anti-Helicobacter pylori therapy.



    		+-nlWorld J Gastroenterol 17(35):3971-5 (2011)
    1502007Diet, H pylori infection and gastric cancer: evidence and controversies.



    		+-nlWorld J Gastroenterol 13(21):2901-12 (2007)
    1512007Emerging role of IL-23/IL-17 axis in H pylori-associated pathology.



    		+-nlWorld J Gastroenterol 13(42):5547-51 (2007)
    1522005Acid acclimation by Helicobacter pylori.



    		+-nlPhysiology (Bethesda) 20(-):429-38 (2005)
    1532010Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma.



    		+-nlJ Biomed Biotechnol 2010(-):104918 (2010)
    1542009Coadaptation of Helicobacter pylori and humans: ancient history, modern implications.



    		+-nlJ Clin Invest 119(9):2475-87 (2009)
    1552010Role of innate immunity in Helicobacter pylori-induced gastric malignancy.



    		+-nlPhysiol Rev 90(3):831-58 (2010)
    1562007The language used by Helicobacter pylori to regulate human cells.



    		+-nlJ Infect Dis 196(1):6-9 (2007)
    1572010Helicobacter pylori and gastric cancer: factors that modulate disease risk.



    		+-nlClin Microbiol Rev 23(4):713-39 (2010)
    1582008Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?



    		+-nlRheumatology (Oxford) 47(9):1342-7 (2008)
    1592010Iron deficiency anaemia can be improved after eradication of Helicobacter pylori.



    		+-nlPostgrad Med J 86(1015):272-8 (2010)
    1602004Eradication of Helicobacter pylori: a clinical update.



    		+-nlMedGenMed 6(1):19 (2004)
    1612007Type IV secretion system in Helicobacter pylori: a new insight into pathogenicity.



    		+-nlChin Med J (Engl) 120(23):2138-42 (2007)
    1622002Risks and benefits of Helicobacter pylori eradication: current status.



    		+-nlCan J Gastroenterol 16(1):57-62 (2002)
    1632011Helicobacter pylori treatment in the hospital setting: a potential model for developing quality improvement initiatives to prevent missed test results.



    		+-nlCan J Gastroenterol 25(10):542 (2011)
    1642004Helicobacter pylori and the prevention of gastric cancer.



    		+-nlCan J Gastroenterol 18(5):295-302 (2004)
    1652005An update on anti-Helicobacter pylori treatment in children.



    		+-nlCan J Gastroenterol 19(7):441-5 (2005)
    1662005Noninvasive diagnostic tests for Helicobacter pylori infection in children.



    		+-nlCan J Gastroenterol 19(7):433-9 (2005)
    1672005Extradigestive manifestation of Helicobacter pylori infection in children and adolescents.



    		+-nlCan J Gastroenterol 19(7):421-4 (2005)
    1682005Modulation of host cell signal transduction pathways by Helicobacter pylori infection.



    		+-nlCan J Gastroenterol 19(7):415-20 (2005)
    1692010Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis.



    		+-nlFuture Oncol 6(5):851-62 (2010)
    1702007Helicobacter pylori in children: an Indian perspective.



    		+-nlIndian Pediatr 44(10):761-70 (2007)
    1712009Infection with Helicobacter pylori. Prevalence, research and impact of antibiotic resistance.



    		+-nlRev Esp Enferm Dig 101(11):743-56 (2009)
    1722006Gastric angiogenesis and Helicobacter pylori infection.



    		+-nlRev Esp Enferm Dig 98(7):527-41 (2006)
    1732009Current knowledge on helicobacter pylori infection in end stage renal disease patients.



    		+-nlSaudi J Kidney Dis Transpl 20(6):969-74 (2009)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.